Kelly, E., Greenland, M., de Whalley, P. C., Aley, P. K., Plested, E. L., Singh, N., Koleva, S., Tonner, S., Macaulay, G. C., Read, R. C., Ramsay, M., Cameron, J. C., Turner, D. P., Heath, P. T., Bernatoniene, J., Connor, P., Cathie, K., Faust, S. N., Banerjee, I., Cantrell, L., …Com-COV3 Study Group, C.-C. S. G. (2023). Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial. Journal of Infection, 87(3), 230-241. https://doi.org/10.1016/j.jinf.2023.06.007